DMIIU 8-K: Material agreement

Filed with the SEC on · accession 0001477932-26-007137

DMIIU filed a 8-K (current report) with the SEC on Nov 18, 2026. Drugs Made In America Acquisition II Corp. received a $250,000 installment under its convertible notes financing, consolidating prior notes into a $700,000 note maturing June 30, 2027, and delivered a nonbinding proposal to acquire Alpha AI Biotech Group at a $600 million pre-money valuation…

Summary of the filing

Drugs Made In America Acquisition II Corp. received a $250,000 installment under its convertible notes financing, consolidating prior notes into a $700,000 note maturing June 30, 2027, and delivered a nonbinding proposal to acquire Alpha AI Biotech Group at a $600 million pre-money valuation payable in 60 million shares plus up to 30 million earn-out shares.

Key details

Convertible notes financing commitment$1.4M
Amount funded to date under Convertible Notes Financing$700K
Remaining available under the Agreement$700K
Latest installment funded$250K
Consolidated Note principal amount$700K
Pre-money equity valuation of Alpha$600.0M
RegistrantDrugs Made In America Acquisition II Corp.
Investor providing convertible notes financingTal Alpha Yezum Vekidum Asakim (2003) Ltd.
Potential business combination targetAlpha AI Biotech Group
Ceo of the investor and director of alphaAlon Izidor Tal

✦ Ask GOAX AI about this filing — what it means for DMIIU, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for DMIIU?

Click here

Frequently asked questions

What did DMIIU file with the SEC on Nov 18, 2026?

DMIIU filed a 8-K (Material agreement). Drugs Made In America Acquisition II Corp. received a $250,000 installment under its convertible notes financing, consolidating prior notes into a $700,000 note maturing June 30, 2027, and delivered a nonbinding proposal to acquire Alpha AI Biotech Group at a $600 million pre-money valuation payable in 60 million shares plus up to 30 million earn-out shares.

What does a material agreement mean for DMIIU stock?

A contract important enough that investors need to know about it — a big customer contract, a loan, a merger agreement or a partnership.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other DMIIU SEC filings

Get alerts when DMIIU files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days